18F-Al-NOTA-MATBBN

N/A

Report date: 2025/11/20 16:02:28

NME

Base Information

Drug Name18F-Al-NOTA-MATBBN

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionGastrin releasing peptide receptor antagonistsPositron-emission tomography enhancers

TargetsGastrin releasing peptide receptor

Therapy Area/IndicationsProstatic NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesWuxi No. 4 People

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWuxi No. 4 People

Active IndicationsN/A

Inactive IndicationsProstatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A